Malaria Journal

Table 2 Factors associated oocyst and sporozoite prevalence in Anopheline vectors in Rufiji and Kilombero-Ulanga Districts, January 2002-July 2004

From: Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission

Variable	Oocyst prevalence		Sporozoite prevalence
	OR [95% CI]	P value	OR [95% CI]	P value
District
Kilombero-Ulanga	Referent	Referent	Referent	Referent
Rufiji	0.72 [0.38-1.37]	0.31	2.51 [2.22-2.84]	<0.001
Period
January 2002-February 2003	Referent	Referent	Referent	Referent
March 2003-July 2004	1.09 [0.76-1.58]	0.63	1.44 [1.28-1.61]	<0.001
Anti-malarial in use
SP	Referent	Referent	Referent	Referent
AS + SP	3.91 [2.88-5.33]	<0.001	0.92 [0.72-1.18]	0.51
Anopheline species
An. gambiae s.l	Referent	Referent	Referent	Referent
An. funestus	1.19 [0.88-1.61]	0.26	0.96 [0.85-1.07]	0.45

95% CI = 95% confidence interval.
SP = Sulphadoxine-pyrimethamine.
AS + SP = Artesunate co-administered with sulphadoxine-pyrimethamine.

Back to article page

ISSN: 1475-2875

Contact us

Submission enquiries: journalsubmissions@springernature.com